181 related articles for article (PubMed ID: 17885300)
1. Trends in perimortal conditions and mortality rates among HIV-infected patients.
Hooshyar D; Hanson DL; Wolfe M; Selik RM; Buskin SE; McNaghten AD
AIDS; 2007 Oct; 21(15):2093-100. PubMed ID: 17885300
[TBL] [Abstract][Full Text] [Related]
2. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of an observational database to assess antiretroviral treatment trends in India.
Cecelia AJ; Christybai P; Anand S; Jayakumar K; Gurunathan T; Vidya P; Solomon S; Kumarasamy N
Natl Med J India; 2006; 19(1):14-7. PubMed ID: 16570679
[TBL] [Abstract][Full Text] [Related]
4. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
[TBL] [Abstract][Full Text] [Related]
5. The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users.
Ferreros I; Lumbreras B; Hurtado I; Pérez-Hoyos S; Hernández-Aguado I
Addiction; 2008 Apr; 103(4):651-9. PubMed ID: 18339110
[TBL] [Abstract][Full Text] [Related]
6. Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005.
Buchacz K; Baker RK; Moorman AC; Richardson JT; Wood KC; Holmberg SD; Brooks JT;
AIDS; 2008 Jul; 22(11):1345-54. PubMed ID: 18580614
[TBL] [Abstract][Full Text] [Related]
7. Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment.
Palella FJ; Baker RK; Buchacz K; Chmiel JS; Tedaldi EM; Novak RM; Durham MD; Brooks JT;
AIDS; 2011 Sep; 25(15):1865-76. PubMed ID: 21811144
[TBL] [Abstract][Full Text] [Related]
8. Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.
Hessol NA; Kalinowski A; Benning L; Mullen J; Young M; Palella F; Anastos K; Detels R; Cohen MH
Clin Infect Dis; 2007 Jan; 44(2):287-94. PubMed ID: 17173233
[TBL] [Abstract][Full Text] [Related]
9. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
[TBL] [Abstract][Full Text] [Related]
10. HIV related and non-HIV related mortality before and after the introduction of highly active antiretroviral therapy (HAART) in Norway compared to the general population.
Ormaasen V; Sandvik L; Dudman SG; Bruun JN
Scand J Infect Dis; 2007; 39(1):51-7. PubMed ID: 17366013
[TBL] [Abstract][Full Text] [Related]
11. Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States.
Chorba TL; Holman RC; Clarke MJ; Evatt BL
Am J Hematol; 2001 Apr; 66(4):229-40. PubMed ID: 11279632
[TBL] [Abstract][Full Text] [Related]
12. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
[TBL] [Abstract][Full Text] [Related]
13. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
[TBL] [Abstract][Full Text] [Related]
14. HIV-related mortality among tuberculosis patients in The Netherlands, 1993-2001.
Haar CH; Cobelens FG; Kalisvaart NA; van Gerven PJ; van der Have JJ
Int J Tuberc Lung Dis; 2007 Sep; 11(9):1038-41. PubMed ID: 17918662
[TBL] [Abstract][Full Text] [Related]
15. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
16. Changes in mortality following HIV and AIDS and estimation of the number of people living with diagnosed HIV/AIDS in Australia, 1981-2003.
Nakhaee F; Black D; Wand H; McDonald A; Law M
Sex Health; 2009 Jun; 6(2):129-34. PubMed ID: 19457292
[TBL] [Abstract][Full Text] [Related]
17. [Opportunistic infections. Developments and trends since establishment of HAART therapy].
Marquardt T; Jablonowski H
MMW Fortschr Med; 2001 Apr; 143 Suppl 1():56-60. PubMed ID: 11373785
[TBL] [Abstract][Full Text] [Related]
18. Changing HIV infection-related mortality rate and causes of death among persons with HIV infection before and after the introduction of highly active antiretroviral therapy: analysis of all HIV-related deaths in Barbados, 1997-2005.
Kumar A; Kilaru KR; Forde S; Roach TC
J Int Assoc Physicians AIDS Care (Chic); 2006 Sep; 5(3):109-14. PubMed ID: 16928879
[TBL] [Abstract][Full Text] [Related]
19. Mortality and loss to follow-up among HAART initiators in rural South Africa.
MacPherson P; Moshabela M; Martinson N; Pronyk P
Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):588-93. PubMed ID: 19012940
[TBL] [Abstract][Full Text] [Related]
20. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
